ERBB2 and breast carcinoma: However, 5 case control studies from Caucasian, 4 from American subgroup, 2 limited studies from Afro-American ethnic group and 8 studies from European ethnicity showed no association of Her2 polymorphism with breast cancer risk in all the models (Table 3) (Figs 7–12).